Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Takeda Hospital Group Joins TriNetX Network to Revolutionize Medical Care in Japan 2024-03-19 12:01
Cognizant to apply generative AI to enhance drug discovery for pharmaceutical clients with NVIDIA BioNeMo 2024-03-19 12:01
Breakthrough in Treatment of Cervical High-Grade Squamous Intraepithelial Lesion: Release of Positive Results from Multicenter Phase III Global Clinical Study 2024-03-19 10:24
ICP DAS-BMP Secures Pivotal TPU Deals with Medical Materials Leaders in U.S. and Japan, Boosts Product Reliability 2024-03-19 08:56
Sanyou Bio and BioGeometry join forces to create a next-generation Antibody Drug Discovery Platform driven by AIGC 2024-03-19 08:00
Innovent Announces Primary Endpoint Met in the Second Phase 2 Clinical Trial of IBI302 (anti-VEGF/complement) in Treating Neovascular Age-related Macular Degeneration (nAMD) 2024-03-19 08:00
Reproductive health experts collaborate in multi-centre study with Gene Solutions to develop next-generation prenatal genetic screening test that predicts for adverse pregnancy complications 2024-03-19 07:01
Alma launches a special edition of Soprano Titanium with a breakthrough applicator to boost hair removal treatment speed 2024-03-19 07:00
QDOSE® Platform Partnership for Personalised Dosimetry in Radiopharmaceutical Therapy 2024-03-19 05:19
Abcam appoints Markus Lusser as new President 2024-03-18 22:20
Lunit Expands Presence in Europe: to Deliver AI-powered Cancer Screening Solution to France and Portugal 2024-03-18 21:00
WuXi AppTec Revenue Surpassed RMB40 Billion in 2023, and Adjusted Non-IFRS Net Profit Exceeded RMB10 Billion for the First Time 2024-03-18 20:32
Aquedeon Medical Announces First Patient Enrolled in the IDE Study of Duett(TM) Vascular Graft System 2024-03-18 20:00
EDAN and GH Labs Collaborate to Develop AI-Enabled Ultrasound Devices 2024-03-18 19:45
Positive results from Phase II clinical trial (CGZ203 study) of Chiglitazar monotherapy for non-alcoholic steatohepatitis 2024-03-18 19:25
KeChow Pharma Announces NMPA Approval of Tunlametinib (HL-085) as the First Targeted Therapy for Patients with NRAS Mutated Advanced Melanoma and Previously Treated with PD-1/PD-L1 2024-03-18 18:02
Cambrex Nears Completion of 5-year, $100-Million-Dollar Investment Plan, One Year Ahead of Schedule 2024-03-18 18:00
Everest Medicines Strengthens Management Team with Appointments of Chief Medical Officer and Chief Product Officer 2024-03-18 09:00
Mediwave Earns Global Recognition at GLOMO Awards 2024 for Emergency Response HealthTech 2024-03-18 08:00
SOPHiA GENETICS and The French Kidney Cancer Research Network (UroCCR) Publish Results from Multiyear Collaboration 2024-03-15 18:00
1 85 86 87 88 89 962